|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |review |
 |
The
occurrence of cross-reactivities with neurocysticercosis indicates the
necessity for retesting sera with species-specific antigens, for rare patients
with neurologic disorders. The same Western Blot system is coming in for Taenia spp.
Are sufficient numbers of persons at risk to make vaccine development more than a dream?
Immunological matters lie at the edge of the future.
|